Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Does a Mandatory Non- medical Switch from Originator to Biosimilar Etanercept Lead to Increase in Healthcare Use and Costs? A Danish Register- based Study of 1620 Patients with Infl ammatory Arthritis

Research output: Contribution to journalConference abstract in journalResearchpeer-review

View graph of relations
Original languageEnglish
Article number0205
JournalArthritis & Rheumatology
Volume71
Issue numberS10
Number of pages3
ISSN1537-2960
Publication statusPublished - 2019

Bibliographical note

COPECARE

ID: 59055192